Medtronic Leads in Question Again

Medtronic leads show high fracture rates with ICD therapy defibrillators.

A lead manufactured by Medtronic Inc. has a higher fracture rate when used with implantable cardiac resynchronization (ICD) therapy defibrillators compared with conventional ICDs. A study released May 5 at the Heart Rhythm Society’s annual meeting in San Francisco, Calif., showed that the fracture rate with the Sprint Fidelis lead was 2.4 percent with the advanced ICD, compared with 1 percent when used with a conventional ICD.

Medtronic’s Sprint Fidelis lead was recalled in 2007. The recall resulted in a $268 million legal settlement.

Medtronic is headquartered in Minneapolis, Minn.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters